SlideShare a Scribd company logo
IN
• Hepatitis is a systemic disease with primary
inflammation of the liver by hepatotropic viruses.
• It can be caused by Hep A , Hep B , Hep C, Hep D
and Hep E.
• Other viruses such as Herpes Simplex, CMV,EBV
can also cause hepatitis.
HEPATITIS A
• Hepatitis A is caused by a picornavirus
• It causes an acute form of hepatitis and does not have a
chronic stage.
• The patient's immune system makes antibodies against HAV
that confer immunity against future infection.
• PERIOD OF INFECTIVITY :2 weeks before to 1 week
after the onset of jaundice.
• INCUBATION PERIOD : 10-50 days [usually 25 to 30
days].
• MODE OF TRANSMISSION : fecal-oral route
• SYMPTOMS : Non specific symptoms such as fever,
chills ,headache, fatigue, generalized weakness,
aches and pains, followed by anorexia, nausea,
vomiting, dark urine and jaundice.
Treatment: There is no specific treatment,
supportive care is given until symptoms
disappear.
PREVENTION : Proper hygiene and sanitation
measures
Immune globins should be given to all close
personal contacts with Hep A.
Vaccination is also present.
HEPATITIS B
• HBV which is a DNA virus
• It can cause both acute and chronic infections.
• Many people have no symptoms during the initial
infection.
• The acute illness causes liver inflammation,
vomiting, jaundice.
• Chronic hep B eventually causes cirrhosis and liver
cancer.
DANE PARTICLE
• INCUBATION PERIOD : 60-90 days
• MODE OF TRANSMISSION : The virus is transmitted
by exposure to infectious blood or body fluids.
Vertical transmission can take place.
Intravenous drug use and sexual intercourse are the
most frequent routes of infection.
Other risk factors include working in healthcare,
blood transfusions, dialysis etc.
The hepatitis B viruses cannot be spread by holding
hands, sharing eating utensils, kissing, hugging,
coughing, sneezing, or breastfeeding.
• TREATMENT : Interferon alfa, lamivudine , Adefovir
dipivoxil
• VACCINATION : As per EPI Schedule
0/1/6 months after contact.
HEPATITIS C
• Hepatitis C virus (HCV)
• During the initial infection people often have mild
or no symptoms. Occasionally a fever, dark urine,
abdominal pain, and yellow tinged skin occurs.
• The virus persists in the liver in about 75% to 85%
of those initially infected.
• INCUBATION PERIOD : 40-120 days
HCV ANTIBODY :Not useful in acute phase as it takes at
least 4 weeks to develop.
HCV RNA :Mainly used in monitoring the response to
antiviral therapy.
TREATMENT :INTERFERON AND RIBAVIRIN
HEPATITIS D
• Hepatitis D virus (HDV), a small spherical enveloped
viroid
• HDV is considered to be a subviral satellite because
it can propagate only in the presence of the
hepatitis B virus (HBV). Transmission of HDV can
occur either via simultaneous infection with HBV
(coinfection) or superimposed on chronic hepatitis
B or hepatitis B carrier state (superinfection).
• Both superinfection and coinfection with HDV
results in more severe complications compared to
infection with HBV alone. These complications
include a greater likelihood of experiencing liver
failure in acute infections and a rapid progression
to liver cirrhosis, with an increased risk of
developing liver cancer in chronic infections. In
combination with hepatitis B virus, hepatitis D has
the highest fatality rate of all the hepatitis
infections, at 20%.
HEPATITIS E
• HEV is a positive-sense, single-stranded,
nonenveloped, RNA icosahedral virus; HEV has a fecal-
oral transmission route.
• Hepatitis E occasionally develops into an acute, severe
liver disease, and is fatal in about 2% of all cases.
• Clinically, it is comparable to hepatitis A, but in
pregnant women, the disease is more often severe and
is associated with a clinical syndrome called fulminant
liver failure. Pregnant women, especially those in the
third trimester, suffer an elevated mortality rate from
the disease of around 20%.
Viral hep
Viral hep
Viral hep
Viral hep

More Related Content

What's hot

Hepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUSHepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUS
ABHISHEK
 
syed fazil
syed fazilsyed fazil
syed fazil
Syed Ali
 
Viral hepatitis a brief insight- By rxvichu :)
Viral hepatitis  a brief insight- By rxvichu :)Viral hepatitis  a brief insight- By rxvichu :)
Viral hepatitis a brief insight- By rxvichu :)
RxVichuZ
 
Hepatitis awareness ppt | Eliminate Hepatitis
Hepatitis awareness ppt | Eliminate HepatitisHepatitis awareness ppt | Eliminate Hepatitis
Hepatitis awareness ppt | Eliminate Hepatitis
ExpressClinicsIndia
 
Hepatitis Ppt Sept 2006
Hepatitis    Ppt   Sept 2006Hepatitis    Ppt   Sept 2006
Hepatitis Ppt Sept 2006
NorthTec
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
Mahmoud Ashraf
 
Hepatitis B virus
Hepatitis B virus Hepatitis B virus
Hepatitis B virus
Pubali Biswas
 
Journal of Hepatitis Research
Journal of Hepatitis ResearchJournal of Hepatitis Research
Journal of Hepatitis Research
Austin Publishing Group
 
Hepatitis D
Hepatitis DHepatitis D
Hepatitis D
arosababa
 
Hepatitis a & e
Hepatitis a & eHepatitis a & e
Hepatitis a & e
adityadayana
 
Hepatitis
Hepatitis Hepatitis
Hepatitis
Harindu Udapitiya
 
Acute viral hepatitis
Acute viral hepatitisAcute viral hepatitis
Acute viral hepatitis
Raeez Basheer
 
Hepatitis A,B,C,D,E,F,G, its treatment and management including its pathophys...
Hepatitis A,B,C,D,E,F,G, its treatment and management including its pathophys...Hepatitis A,B,C,D,E,F,G, its treatment and management including its pathophys...
Hepatitis A,B,C,D,E,F,G, its treatment and management including its pathophys...
Jack Frost
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
Dr Saikiran Reddy
 
Hepatitis
HepatitisHepatitis
HBV infection for dental students
HBV infection for dental students HBV infection for dental students
HBV infection for dental students
KSU
 
HEPATITIS E
HEPATITIS EHEPATITIS E
HEPATITIS E
MAHESWARI JAIKUMAR
 
Viral hepatitis
Viral hepatitisViral hepatitis
Hepatitis fazil
Hepatitis fazilHepatitis fazil
Hepatitis fazil
gokul13
 
Hepatitis Power Point
Hepatitis  Power  PointHepatitis  Power  Point
Hepatitis Power Point
Kassandra.J
 

What's hot (20)

Hepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUSHepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUS
 
syed fazil
syed fazilsyed fazil
syed fazil
 
Viral hepatitis a brief insight- By rxvichu :)
Viral hepatitis  a brief insight- By rxvichu :)Viral hepatitis  a brief insight- By rxvichu :)
Viral hepatitis a brief insight- By rxvichu :)
 
Hepatitis awareness ppt | Eliminate Hepatitis
Hepatitis awareness ppt | Eliminate HepatitisHepatitis awareness ppt | Eliminate Hepatitis
Hepatitis awareness ppt | Eliminate Hepatitis
 
Hepatitis Ppt Sept 2006
Hepatitis    Ppt   Sept 2006Hepatitis    Ppt   Sept 2006
Hepatitis Ppt Sept 2006
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Hepatitis B virus
Hepatitis B virus Hepatitis B virus
Hepatitis B virus
 
Journal of Hepatitis Research
Journal of Hepatitis ResearchJournal of Hepatitis Research
Journal of Hepatitis Research
 
Hepatitis D
Hepatitis DHepatitis D
Hepatitis D
 
Hepatitis a & e
Hepatitis a & eHepatitis a & e
Hepatitis a & e
 
Hepatitis
Hepatitis Hepatitis
Hepatitis
 
Acute viral hepatitis
Acute viral hepatitisAcute viral hepatitis
Acute viral hepatitis
 
Hepatitis A,B,C,D,E,F,G, its treatment and management including its pathophys...
Hepatitis A,B,C,D,E,F,G, its treatment and management including its pathophys...Hepatitis A,B,C,D,E,F,G, its treatment and management including its pathophys...
Hepatitis A,B,C,D,E,F,G, its treatment and management including its pathophys...
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
HBV infection for dental students
HBV infection for dental students HBV infection for dental students
HBV infection for dental students
 
HEPATITIS E
HEPATITIS EHEPATITIS E
HEPATITIS E
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Hepatitis fazil
Hepatitis fazilHepatitis fazil
Hepatitis fazil
 
Hepatitis Power Point
Hepatitis  Power  PointHepatitis  Power  Point
Hepatitis Power Point
 

Similar to Viral hep

Hepatitis-WPS Office.pptx
Hepatitis-WPS Office.pptxHepatitis-WPS Office.pptx
Hepatitis-WPS Office.pptx
Sudipta Roy
 
Hepatitis.pptx
Hepatitis.pptxHepatitis.pptx
Hepatitis.pptx
Imtiyaz60
 
Hepatities
HepatitiesHepatities
Hepatities
abbassimohammed1
 
Viral hepatitis in human
Viral hepatitis in humanViral hepatitis in human
Viral hepatitis in human
Shane Prasad
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
George Kariuki
 
Viral Hepatitis ( Presentation ) Hepatology ( Medicine )
Viral Hepatitis ( Presentation ) Hepatology ( Medicine )Viral Hepatitis ( Presentation ) Hepatology ( Medicine )
Viral Hepatitis ( Presentation ) Hepatology ( Medicine )
NoorUlAmin70
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
kemboiarn
 
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
druroojarshad9454
 
hepatitis b and d
hepatitis b and dhepatitis b and d
hepatitis b and d
DrAshlyAlex91
 
Acute hepatitis
Acute hepatitis Acute hepatitis
Acute hepatitis
Syed Ali
 
Hepatitis e virus virology presentations
Hepatitis e virus virology presentationsHepatitis e virus virology presentations
Hepatitis e virus virology presentations
HumzaHumza2
 
Hepatitis D
Hepatitis DHepatitis D
Hepatitis D
Prabita Shrestha
 
Hepatitis
HepatitisHepatitis
Hepatitis
Ahmed Essam
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
MEEQAT HOSPITAL
 
Hepatitis B
Hepatitis BHepatitis B
Management of Viral Hepatitis in Immunocompromised Patients
Management of Viral Hepatitis in Immunocompromised PatientsManagement of Viral Hepatitis in Immunocompromised Patients
Management of Viral Hepatitis in Immunocompromised Patients
Mohammed A Suwaid
 
Hepatitis B, introduction, symptoms, diagnosis, treatment, case presentation.
Hepatitis B, introduction, symptoms, diagnosis, treatment, case presentation.Hepatitis B, introduction, symptoms, diagnosis, treatment, case presentation.
Hepatitis B, introduction, symptoms, diagnosis, treatment, case presentation.
katkitty0703
 
Hepatitis.pptx
Hepatitis.pptxHepatitis.pptx
Hepatitis.pptx
PriyaCyrus
 
NATIONAL GUIDELINES FOR VIRAL HEPATITIS.pptx
NATIONAL GUIDELINES FOR VIRAL HEPATITIS.pptxNATIONAL GUIDELINES FOR VIRAL HEPATITIS.pptx
NATIONAL GUIDELINES FOR VIRAL HEPATITIS.pptx
DrRajatTuteja1
 
Hepatitis E yashwant kumar
Hepatitis E yashwant kumar Hepatitis E yashwant kumar
Hepatitis E yashwant kumar
Yashwant Kumar
 

Similar to Viral hep (20)

Hepatitis-WPS Office.pptx
Hepatitis-WPS Office.pptxHepatitis-WPS Office.pptx
Hepatitis-WPS Office.pptx
 
Hepatitis.pptx
Hepatitis.pptxHepatitis.pptx
Hepatitis.pptx
 
Hepatities
HepatitiesHepatities
Hepatities
 
Viral hepatitis in human
Viral hepatitis in humanViral hepatitis in human
Viral hepatitis in human
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Viral Hepatitis ( Presentation ) Hepatology ( Medicine )
Viral Hepatitis ( Presentation ) Hepatology ( Medicine )Viral Hepatitis ( Presentation ) Hepatology ( Medicine )
Viral Hepatitis ( Presentation ) Hepatology ( Medicine )
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
VIRAL HEPATITIS (an overview) ;presentation by Dr. Urooj Arshad.
 
hepatitis b and d
hepatitis b and dhepatitis b and d
hepatitis b and d
 
Acute hepatitis
Acute hepatitis Acute hepatitis
Acute hepatitis
 
Hepatitis e virus virology presentations
Hepatitis e virus virology presentationsHepatitis e virus virology presentations
Hepatitis e virus virology presentations
 
Hepatitis D
Hepatitis DHepatitis D
Hepatitis D
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
Management of Viral Hepatitis in Immunocompromised Patients
Management of Viral Hepatitis in Immunocompromised PatientsManagement of Viral Hepatitis in Immunocompromised Patients
Management of Viral Hepatitis in Immunocompromised Patients
 
Hepatitis B, introduction, symptoms, diagnosis, treatment, case presentation.
Hepatitis B, introduction, symptoms, diagnosis, treatment, case presentation.Hepatitis B, introduction, symptoms, diagnosis, treatment, case presentation.
Hepatitis B, introduction, symptoms, diagnosis, treatment, case presentation.
 
Hepatitis.pptx
Hepatitis.pptxHepatitis.pptx
Hepatitis.pptx
 
NATIONAL GUIDELINES FOR VIRAL HEPATITIS.pptx
NATIONAL GUIDELINES FOR VIRAL HEPATITIS.pptxNATIONAL GUIDELINES FOR VIRAL HEPATITIS.pptx
NATIONAL GUIDELINES FOR VIRAL HEPATITIS.pptx
 
Hepatitis E yashwant kumar
Hepatitis E yashwant kumar Hepatitis E yashwant kumar
Hepatitis E yashwant kumar
 

Recently uploaded

Top five deadliest dog breeds in America
Top five deadliest dog breeds in AmericaTop five deadliest dog breeds in America
Top five deadliest dog breeds in America
Bisnar Chase Personal Injury Attorneys
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
Colégio Santa Teresinha
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
taiba qazi
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
Celine George
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 
A Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdfA Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdf
Jean Carlos Nunes Paixão
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRMHow to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
Celine George
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
WaniBasim
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
IreneSebastianRueco1
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
 
Smart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICTSmart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICT
simonomuemu
 
Film vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movieFilm vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movie
Nicholas Montgomery
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
heathfieldcps1
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
Assessment and Planning in Educational technology.pptx
Assessment and Planning in Educational technology.pptxAssessment and Planning in Educational technology.pptx
Assessment and Planning in Educational technology.pptx
Kavitha Krishnan
 

Recently uploaded (20)

Top five deadliest dog breeds in America
Top five deadliest dog breeds in AmericaTop five deadliest dog breeds in America
Top five deadliest dog breeds in America
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 
A Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdfA Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdf
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRMHow to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
 
Smart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICTSmart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICT
 
Film vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movieFilm vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movie
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
Assessment and Planning in Educational technology.pptx
Assessment and Planning in Educational technology.pptxAssessment and Planning in Educational technology.pptx
Assessment and Planning in Educational technology.pptx
 

Viral hep

  • 1. IN
  • 2. • Hepatitis is a systemic disease with primary inflammation of the liver by hepatotropic viruses. • It can be caused by Hep A , Hep B , Hep C, Hep D and Hep E. • Other viruses such as Herpes Simplex, CMV,EBV can also cause hepatitis.
  • 3. HEPATITIS A • Hepatitis A is caused by a picornavirus • It causes an acute form of hepatitis and does not have a chronic stage. • The patient's immune system makes antibodies against HAV that confer immunity against future infection.
  • 4. • PERIOD OF INFECTIVITY :2 weeks before to 1 week after the onset of jaundice. • INCUBATION PERIOD : 10-50 days [usually 25 to 30 days]. • MODE OF TRANSMISSION : fecal-oral route • SYMPTOMS : Non specific symptoms such as fever, chills ,headache, fatigue, generalized weakness, aches and pains, followed by anorexia, nausea, vomiting, dark urine and jaundice.
  • 5.
  • 6. Treatment: There is no specific treatment, supportive care is given until symptoms disappear. PREVENTION : Proper hygiene and sanitation measures Immune globins should be given to all close personal contacts with Hep A. Vaccination is also present.
  • 7.
  • 8. HEPATITIS B • HBV which is a DNA virus • It can cause both acute and chronic infections. • Many people have no symptoms during the initial infection. • The acute illness causes liver inflammation, vomiting, jaundice. • Chronic hep B eventually causes cirrhosis and liver cancer.
  • 10. • INCUBATION PERIOD : 60-90 days • MODE OF TRANSMISSION : The virus is transmitted by exposure to infectious blood or body fluids. Vertical transmission can take place. Intravenous drug use and sexual intercourse are the most frequent routes of infection. Other risk factors include working in healthcare, blood transfusions, dialysis etc. The hepatitis B viruses cannot be spread by holding hands, sharing eating utensils, kissing, hugging, coughing, sneezing, or breastfeeding.
  • 11.
  • 12.
  • 13. • TREATMENT : Interferon alfa, lamivudine , Adefovir dipivoxil • VACCINATION : As per EPI Schedule 0/1/6 months after contact.
  • 14. HEPATITIS C • Hepatitis C virus (HCV) • During the initial infection people often have mild or no symptoms. Occasionally a fever, dark urine, abdominal pain, and yellow tinged skin occurs. • The virus persists in the liver in about 75% to 85% of those initially infected.
  • 15. • INCUBATION PERIOD : 40-120 days
  • 16. HCV ANTIBODY :Not useful in acute phase as it takes at least 4 weeks to develop. HCV RNA :Mainly used in monitoring the response to antiviral therapy. TREATMENT :INTERFERON AND RIBAVIRIN
  • 17. HEPATITIS D • Hepatitis D virus (HDV), a small spherical enveloped viroid • HDV is considered to be a subviral satellite because it can propagate only in the presence of the hepatitis B virus (HBV). Transmission of HDV can occur either via simultaneous infection with HBV (coinfection) or superimposed on chronic hepatitis B or hepatitis B carrier state (superinfection).
  • 18. • Both superinfection and coinfection with HDV results in more severe complications compared to infection with HBV alone. These complications include a greater likelihood of experiencing liver failure in acute infections and a rapid progression to liver cirrhosis, with an increased risk of developing liver cancer in chronic infections. In combination with hepatitis B virus, hepatitis D has the highest fatality rate of all the hepatitis infections, at 20%.
  • 19. HEPATITIS E • HEV is a positive-sense, single-stranded, nonenveloped, RNA icosahedral virus; HEV has a fecal- oral transmission route. • Hepatitis E occasionally develops into an acute, severe liver disease, and is fatal in about 2% of all cases. • Clinically, it is comparable to hepatitis A, but in pregnant women, the disease is more often severe and is associated with a clinical syndrome called fulminant liver failure. Pregnant women, especially those in the third trimester, suffer an elevated mortality rate from the disease of around 20%.